©연합뉴스

Robert F. Kennedy Jr., serving as a central figure in the Trump administration's health policy, has initiated an extensive federal investigation into the potential links between vaccines and autism. Pledging to provide a definitive answer to the "autism epidemic" by September, Kennedy is driving a significant shift in federal research priorities despite long-standing scientific consensus regarding vaccine safety.

President Donald Trump and Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. have announced a series of aggressive actions aimed at addressing the rising rates of autism in the United States. Kennedy has committed to delivering a comprehensive report by September, signaling a new era of federal scrutiny over environmental and medical factors behind neurodevelopmental disorders. This initiative marks a pivot in the national health agenda, placing Kennedy at the forefront of a vast inquiry that has remained largely behind the scenes until recent executive confirmations.

In alignment with this new direction, the Centers for Disease Control and Prevention (CDC) is reportedly planning a large-scale study to re-examine the relationship between vaccines and autism. While mainstream scientific organizations, including the editors of the journal Nature and public broadcasting outlets, emphasize that current research does not support a causal link between immunizations and autism, the CDC’s shift indicates the growing influence of Kennedy over federal science agencies. This move comes as Kennedy and Elon Musk spearhead a broader administrative overhaul, which has already resulted in thousands of layoffs across various health departments as the administration seeks to streamline federal bureaucracy.

The push for a new investigation has created a notable divide among Republicans on Capitol Hill. While some legislators support the effort to find the root cause of autism, others express concern over the potential for increased vaccine hesitancy. These concerns are echoed by public health advocates who point to a measles outbreak in South Carolina as a symptom of a worsening "anti-vax fear campaign." Recent data investigations reveal that childhood vaccination rates are already backsliding across the U.S., with one in six parents reporting that they have intentionally skipped or delayed their children’s vaccines.

Critics have also raised questions regarding the personnel selected to lead these reviews. Reports indicate that at least one Kennedy appointee tasked with reviewing vaccine data lacks a formal medical background and possesses a research history that has been characterized as questionable by the scientific community. Despite these internal and external tensions, the administration remains focused on its September deadline, asserting that a thorough investigation is necessary to restore public trust in health institutions.

As the federal government prepares for this massive inquiry, the scientific community continues to highlight that the rise in autism diagnoses is largely attributed to expanded diagnostic criteria and improved screening methods. However, with Kennedy now holding a powerful position in U.S. science policy, the focus of federal health agencies is poised for a fundamental transformation that will likely have lasting implications for public health policy and national immunization programs.